Profil
Stephen C.
Brown is the founder of Secretory IgA, Inc. Prior to founding Secretory IgA, Inc., he worked as a Chemistry Director at Esperion Therapeutics, Inc. He holds a doctorate degree from the University of California, Berkeley.
Postes actifs de Stephen C. Brown
| Sociétés | Poste | Début |
|---|---|---|
Secretory IgA, Inc.
 Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Fondateur | 20/09/2011 |
Anciens postes connus de Stephen C. Brown
| Sociétés | Poste | Fin |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Stephen C. Brown
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Secretory IgA, Inc.
Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Health Technology |
